| 000 | 01624 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517121508.0 | ||
| 264 | 0 | _c20170811 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1536-4798 | ||
| 024 | 7 |
_a10.1097/ICO.0000000000001046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSzeto, Simon K H | |
| 245 | 0 | 0 |
_aPrevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus. _h[electronic resource] |
| 260 |
_bCornea _cMar 2017 |
||
| 300 |
_a338-342 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a2-Aminopurine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAcyclovir _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aConjunctivitis, Viral _xdrug therapy |
| 650 | 0 | 4 | _aFamciclovir |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHerpes Zoster Ophthalmicus _xdrug therapy |
| 650 | 0 | 4 |
_aHong Kong _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeratitis _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUveitis _xdrug therapy |
| 650 | 0 | 4 |
_aVision Disorders _xepidemiology |
| 650 | 0 | 4 |
_aVisual Acuity _xphysiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChan, Tommy C Y | |
| 700 | 1 | _aWong, Raymond L M | |
| 700 | 1 | _aNg, Alex L K | |
| 700 | 1 | _aLi, Emmy Y M | |
| 700 | 1 | _aJhanji, Vishal | |
| 773 | 0 |
_tCornea _gvol. 36 _gno. 3 _gp. 338-342 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ICO.0000000000001046 _zAvailable from publisher's website |
| 999 |
_c26515433 _d26515433 |
||